Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
India’s upcoming semaglutide boom: A turning point for GLP‑1 drugs, pricing and patient access
With semaglutide’s Indian patent set to expire on March 20, 2026, domestic drugmakers are preparing to enter the GLP‑1 market,…
AstraZeneca Pharma India receives CDSCO approval for Durvalumab for patients with uHCC
AstraZeneca Pharma India, a global, science-led biopharmaceutical company, announced that Central Drugs Standard Control…
Orchid Pharma to set up ₹600 crore India’s first fermentation-based 7-ACA facility
The foundation stone laying ceremony for Orchid Biopharma’s 7-ACA fermentation facility was held in Kathua, Jammu & Kashmir,…
Bharat Biotech celebrates three decades of scientific excellence and global vaccine leadership
Bharat Biotech celebrated 30 years of scientific innovation, public health impact, and its continued commitment to protecting…
Employment discrepancies in pharma hiring stand at 12.1%: AuthBridge Workforce Fraud Files Report
India’s pharmaceutical sector continues to encounter significant hiring-related risks, particularly involving misrepresentation of…
Lupin and Zydus sign licensing agreement for co-marketing innovative Semaglutide injection in India
Global pharma major Lupin has entered into a Licensing and Supply Agreement with Zydus Lifesciences, an innovation-led…
HiMedia Laboratories honored with GS1 India 2026 Excellence Award for innovation in supply chain
HiMedia Laboratories, a global leader in biosciences, has been honored with the prestigious “GS1 India Excellence Award 2026” at…
Glenmark Pharmaceuticals USA to launch Potassium Phosphates injection USP
Glenmark Pharmaceuticals USA has announced the upcoming launch of Potassium Phosphates Injection USP, 15 mmol P / 22 mEq K per 5…
Fourth edition of Dr. Anji Reddy Memorial Lecture reinforces need to advance science and research…
Dr. Reddy’s Laboratories hosted the fourth edition of the Dr. Anji Reddy Memorial Lecture, an annual lecture series instituted on…